- Home
- MRVI vs FDBC Comparison
MRVI vs FDBC Comparison
Compare MRVI & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- FDBC
- Stock Information
- Founded
- MRVI 2014
- FDBC 1902
- Country
- MRVI United States
- FDBC United States
- Employees
- MRVI N/A
- FDBC N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- FDBC Major Banks
- Sector
- MRVI Health Care
- FDBC Finance
- Exchange
- MRVI Nasdaq
- FDBC Nasdaq
- Market Cap
- MRVI 262.9M
- FDBC 226.2M
- IPO Year
- MRVI 2020
- FDBC N/A
- Fundamental
- Price
- MRVI $2.12
- FDBC $42.21
- Analyst Decision
- MRVI Hold
- FDBC
- Analyst Count
- MRVI 9
- FDBC 0
- Target Price
- MRVI $6.54
- FDBC N/A
- AVG Volume (30 Days)
- MRVI 1.7M
- FDBC 6.5K
- Earning Date
- MRVI 05-12-2025
- FDBC 04-23-2025
- Dividend Yield
- MRVI N/A
- FDBC 3.79%
- EPS Growth
- MRVI N/A
- FDBC 32.67
- EPS
- MRVI N/A
- FDBC 3.75
- Revenue
- MRVI $259,185,000.00
- FDBC $81,621,000.00
- Revenue This Year
- MRVI N/A
- FDBC N/A
- Revenue Next Year
- MRVI $11.14
- FDBC N/A
- P/E Ratio
- MRVI N/A
- FDBC $10.76
- Revenue Growth
- MRVI N/A
- FDBC 15.50
- 52 Week Low
- MRVI $1.67
- FDBC $37.00
- 52 Week High
- MRVI $11.56
- FDBC $61.21
- Technical
- Relative Strength Index (RSI)
- MRVI 50.73
- FDBC 55.05
- Support Level
- MRVI $1.96
- FDBC $40.34
- Resistance Level
- MRVI $2.16
- FDBC $41.50
- Average True Range (ATR)
- MRVI 0.12
- FDBC 1.26
- MACD
- MRVI 0.04
- FDBC 0.32
- Stochastic Oscillator
- MRVI 65.31
- FDBC 77.59
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.